CBD Shows Inconsistent Effects on Cognition Across 36 Randomized Trials | Research

The takeaway

A review of 36 randomized controlled trials found CBD had variable effects on cognition depending on the condition and dose, with no consistent cognitive enhancement across populations.

neuropsychologists, psychiatrists, consumers interested in CBD for cognition, clinical researchers

What the researchers found

In healthy participants, CBD showed some effects on cognitive function and sleep quality with various dosing strategies. In Parkinson's disease, 75-300 mg improved daily activities. CBD at 300-400 mg decreased subjective anxiety in psychiatric patients. In psychosis, 600 mg showed inconsistent cognitive results. Up to 1000 mg in schizophrenia and 800 mg in substance use disorders had minimal cognitive effects.

Why it matters

CBD is increasingly marketed for cognitive benefits, but this review of actual RCT data shows the evidence is far more nuanced, with effects varying widely by dose, condition, and outcome measure.

The numbers in context

1,038 articles screened, 36 included. Doses ranged from 75 mg to 1,000 mg. Parkinson's: 75-300 mg improved daily activities. Psychiatric: 300-400 mg reduced anxiety. Psychosis: 600 mg inconsistent. Schizophrenia: up to 1,000 mg minimal cognitive effect. Substance use: up to 800 mg minimal cognitive effect.

How the study worked

Literature review of 36 randomized controlled trials identified from PubMed/Medline using specified search terms. Studies included healthy participants and those with neurological disease, psychiatric disease, psychosis, schizophrenia, and substance use disorders.

What this study cannot tell us

Most studies used acute (single-dose) protocols. Wide variation in CBD dose, formulation, and route of administration. Different cognitive assessments across studies make comparison difficult. Publication bias not formally assessed.

How to read the evidence

Reviews RCT-level evidence across multiple conditions, but highly heterogeneous methods and inconsistent findings limit the overall strength to moderate.

When this study was published

Reviews RCTs available through recent literature search.

The bigger picture

The highly variable results across conditions and doses underscore the need for standardized formulations and dosing protocols before any claims about CBD's cognitive effects can be made with confidence.

Questions still open

Would standardized chronic dosing protocols produce more consistent cognitive outcomes?
Do different CBD formulations produce different cognitive effects?

Common questions

Does CBD improve brain function?

The evidence is mixed. Across 36 clinical trials, CBD showed some benefits for anxiety and Parkinson's disease activities but had minimal or inconsistent effects on cognition in most other conditions studied.

What dose of CBD affects cognition?

Effects varied widely: 75-300 mg showed some benefits in Parkinson's, 300-400 mg reduced anxiety, but doses up to 1,000 mg had minimal cognitive effects in schizophrenia. No single optimal cognitive dose has been established.

Read the original research

Cannabidiol and cognition: a literature review of human randomized controlled trials.

Behavioural pharmacology, 36(5), 203-216

View on PubMed ↗Publisher’s paper ↗

Citation

Singh, Jyotpal; Ellingson, Chase J; Shafiq, M Abdullah; Alcorn, Jane; Neary, J Patrick. (2025). Cannabidiol and cognition: a literature review of human randomized controlled trials.. Behavioural pharmacology, 36(5), 203-216. https://doi.org/10.1097/FBP.0000000000000837